National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

IL-2 plasmid DNA/lipid complex
An immunotherapeutic agent consisting of a plasmid DNA encoding human Interleukin-2 (IL-2) complexed with a cationic lipid, 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethyl ammonium bromide/dioleyl-phosphatidyl-ethanolamine (DMRIE/DOPE), in a 5:1 ratio. Due to the lipophilic nature of this cation liposome complex, this gene transfer system may improve the efficiency of introducing the IL-2 gene into the cells, thereby increasing the production of IL-2 and inducing an immune response. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:IL-2 plasmid DNA/DMRIE/DOPE lipid complex
interleukin-2 DNA/lipid complex
plasmid DNA IL-2 lipid complex
US brand name:Leuvectin
Code name:VCL-1102



Previous:ifosfamide, Ifosfamidum, IGF-1R antagonist BMS-754807, IGF-1R inhibitor OSI-906, IH636 grape seed proanthocyanidin extract
Next:IL-2 recombinant fusion protein ALT-801, IL-2/Lptn gene-modified allogeneic neuroblastoma tumor cell vaccine, iloprost, Ilotycin, Imagent

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov